Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
1.
Chem Commun (Camb) ; 60(50): 6447-6450, 2024 Jun 18.
Article in English | MEDLINE | ID: mdl-38832782

ABSTRACT

The ability of NaCl-type binary transition metal nitrides (incorporating La, Ce, Y, Zr or Hf) to act as catalytic supports facilitating ammonia decomposition was examined. The effect of nitrogen vacancies formed on nitrides can be understood in terms of the ionic radii of the metal cations. A clear correlation between the N2 desorption temperature and catalytic activity was found.

2.
Cancer Med ; 13(16): e70128, 2024 Aug.
Article in English | MEDLINE | ID: mdl-39177082

ABSTRACT

BACKGROUND: Immunofixation electrophoresis (IFE) is the standard method for confirming the presence of a monoclonal protein (M-protein) at multiple myeloma (MM) diagnosis. IFE is also essential at assessment of complete response (CR) and stringent CR during treatment. As the CR assessment is influenced by daratumumab and isatuximab, HYDRASHIFT assays were developed. METHODS: Samples from patients under treatment that included daratumumab or isatuximab were tested and monitored by IFE on the HYDRASYS system using HYDRASHIFT assays (HYDRASYS/HYDRASHIFT) and by IFE on the Epalyzer2 system (Epalyzer). RESULTS: The IFE using HYDRASYS/HYDRASHIFT avoided a false positive caused by drug-related IgG-κ and contributed to accurate assessment of CR. Furthermore, HYDRASYS/HYDRASHIFT detected small M-proteins at early relapse and detected free light chains (FLCs) in patients with renal impairment exhibiting high serum FLCs despite being often missed on Epalyzer. CONCLUSION: Sensitivity and specificity of M-protein detection vary greatly depending on the IFE system and reagents used.


Subject(s)
Antibodies, Monoclonal, Humanized , Antibodies, Monoclonal , Multiple Myeloma , Myeloma Proteins , Humans , Antibodies, Monoclonal/therapeutic use , Multiple Myeloma/drug therapy , Multiple Myeloma/blood , Antibodies, Monoclonal, Humanized/therapeutic use , Myeloma Proteins/analysis , Female , Aged , Male , Middle Aged , Immunoelectrophoresis/methods , Treatment Outcome , Immunoglobulin G/blood , Immunoglobulin kappa-Chains/blood , Indicators and Reagents
SELECTION OF CITATIONS
SEARCH DETAIL